DR5 / TRAIL R2 (Protein | Antibody | cDNA Clone | ELISA Kit)

All DR5 / TRAIL R2 reagents are produced in house and quality controlled, including 10 DR5 / TRAIL R2 Antibody, 27 DR5 / TRAIL R2 Gene, 5 DR5 / TRAIL R2 Lysate, 6 DR5 / TRAIL R2 Protein, 2 DR5 / TRAIL R2 qPCR. All DR5 / TRAIL R2 reagents are ready to use.

DR5 / TRAIL R2 Protein (6)

DR5 / TRAIL R2 Antibody (10)

DR5 / TRAIL R2 cDNA Clone (27)

NM_003842.3
NM_020275.4
XM_005562831.2

In cloning vector

DR5 / TRAIL R2 Lysate (5)

More Product Popular With Customers

DR5 / TRAIL R2 Background

Tumor necrosis factor receptor superfamily, member 1b, official symbol TNFRSF1B, also known as Death receptor 5, CD262, TNF-related apoptosis-inducing ligand receptor 2 (TRAIL R2), is a member of the TNF-receptor superfamily, and contains an intracellular death domain. This receptor can be activated by tumor necrosis factor-related apoptosis inducing ligand (TNFSF1/TRAIL/APO-2L), and transduces an apoptosis signal. Studies with FADD-deficient mice suggested that FADD, a death domain containing adaptor protein, is required for the apoptosis mediated by this protein. TRAIL R2/CD262/TNFRSF1B was purified independently as the only receptor for TRAIL detectable on the surface of two different human cell lines that undergo apoptosis upon stimulation with TRAIL. TRAIL R2/CD262/TNFRSF1B contains two extracellular cysteine-rich repeats, typical for TNF receptor (TNFR) family members, and a cytoplasmic death domain. TRAIL R2/CD262/TNFRSF1B mediates apoptosis via the intracellular adaptor molecule FADD/MORT1. TRAIL receptors can signal both death and gene transcription, functions reminiscent of those of TNFR1 and TRAMP, two other members of the death receptor family. Defects in TRAIL R2/CD262/TNFRSF1B may be a cause of head and neck squamous cell carcinomas (HNSCC) also known as squamous cell carcinoma of the head and neck.

DR5 / TRAIL R2 References

  • Schneider P, et al. (1997) TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity. 7(6): 831-6.
  • Ichikawa K, et al. (2003) TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis. J Immunol. 171(2): 1061-9.
  • Walczak H, et al. (1997) TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 16(17): 5386-97.